Livento Group, Inc.
nugene.comAI Executive Summary
AI-powered analysis of 10-K filing content
Livento Group shows significant red flags including former shell company status, reverse merger transactions, minimal historical revenue ($22k in Q2 2014), and incomplete filing disclosure. The company has undergone multiple business model pivots from jewelry wholesale to biotech through the NuGene acquisition, indicating operational instability.
Red Flags Detected (6)
Former shell company with minimal operations and revenue
Reverse merger structure with NuGene creating accounting complexity
Incomplete 10-K filing content - critical sections appear truncated
3 more red flags detected
Key Takeaways
Company transformed from shell entity to jewelry wholesaler to biotech through acquisitions
Reverse merger accounting treatment suggests NuGene is the true operating entity
2 more takeaways
Filing Overview
What This Means
High Risk Filing: This company is showing signs of financial stress or significant operational challenges.
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Annual Report: Comprehensive filing covering the full fiscal year with audited financial statements.